Integrating downstream mediators of Omega-3 fatty acids into enteral nutrition for improved patient care: An expert panel consensus
Clinical Nutrition · 2026
DOI: 10.1016/j.clnu.2025.11.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Nutrition, 2026. Verfasst von Robert Martindale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oregon Health and Science University, Portland, OR, USA. Electronic address: martindr@ohsu.edu. Hauptthemen laut MEDLINE: Enteral Nutrition, Fatty Acids, Omega-3, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nestlé Health Science.
Abstract (Originalsprache)
Acute inflammation is a crucial biological response necessary for host defense and tissue repair, but unresolved inflammation can contribute to adverse outcomes across critical illness, cardiovascular disease, neurodegeneration, and cancer. Emerging evidence emphasizes that the resolution of inflammation is an active biosynthetic process mediated in part by specialized pro-resolving mediators (SPMs), lipid-derived molecules generated from omega-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (C20:5n-3, EPA) and docosahexaenoic acid (C22:6n-3, DHA). These mediators-including resolvins, protectins, and maresins-exert potent immunomodulatory actions that restore tissue homeostasis and attenuate inflammation without immunosuppression. Despite the established role of SPMs, clinical and preclinical studies demonstrate that SPM biosynthesis is often impaired in disease states, limiting the efficacy of omega-3 PUFA-based nutritional interventions. To explore the potential of standardized SPM enrichment in enteral nutrition (EN), a multidisciplinary panel of experts conducted a Delphi-based consensus process. Consensus statements were developed supporting the rationale for enriching EN with preformed SPMs or their stable precursors to overcome compromised endogenous biosynthesis and enhance clinical benefits. Preliminary human studies suggest that such enrichment may reduce inflammation, improve immune function, and contribute to better outcomes in conditions such as obesity, atherosclerosis, infections, and chronic pain. The panel emphasized the need for rigorously designed clinical trials to determine whether enteral SPMs have measurable clinical effects and, if so, to define effective dosing strategies. Overall, SPM-enriched EN represents a potential advancement in the nutritional modulation of inflammation, warranting further investigation to guide evidence-based clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Oregon Health and Science University, Portland, OR, USA. Electronic address: martindr@ohsu.edu.
- Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic - Rochester, Minnesota, USA.
- Department of Gastroenterology, LIM-35, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
- Department of Clinical Nutrition, Universitair Ziekenhuis Brussel, Brussels, Belgium; Vitality Research Group, Vrije Universiteit Brussel, Brussels, Belgium.
- Department of Anesthesia and Intensive Care Unit, S. Maria Hospital, Terni, Italy; Department of Anesthesiology and Intensive Care, University of Perugia, Italy.
- Department of Intensive Care, New Hospital of Legnano, Legnano, Italy.
Förderung
- Nestlé Health Science
Zitieren
APA
Martindale, R., Mundi, M. S., Waitzberg, D., De Waele, E., Scarcella, M., Umbrello, M., Calder, P. C., Dalli, J., Puthucheary, Z., & van Zanten, A. R. H. (2026). Integrating downstream mediators of Omega-3 fatty acids into enteral nutrition for improved patient care: An expert panel consensus. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.11.014
Vancouver
Martindale R, Mundi MS, Waitzberg D, De Waele E, Scarcella M, Umbrello M, et al. Integrating downstream mediators of Omega-3 fatty acids into enteral nutrition for improved patient care: An expert panel consensus. Clinical Nutrition. 2026. doi:10.1016/j.clnu.2025.11.014
BibTeX
@article{Martindale2026,
author = {Martindale, Robert and Mundi, Manpreet S and Waitzberg, Dan and De Waele, Elisabeth and Scarcella, Marialaura and Umbrello, Michele and Calder, Philip C and Dalli, Jesmond and Puthucheary, Zudin and van Zanten, Arthur R H},
title = {Integrating downstream mediators of Omega-3 fatty acids into enteral nutrition for improved patient care: An expert panel consensus},
journal = {Clinical Nutrition},
year = {2026},
doi = {10.1016/j.clnu.2025.11.014}
}
EUVIMED